FDA Drug Recalls

Recalls / Class II

Class IID-0885-2022

Product

Losartan HCTZ 50/12.5 mg, 90 count bottle Original NDC# 33342-0050-10 Repackaged NDC# 70518-3231-00

Affected lot / code info
Lot # B1377711-100521, exp. date 10/31/2022 B1412137-102621, exp. date 10/31/2022

Why it was recalled

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Recalling firm

Firm
RemedyRepack Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
625 Kolter Dr Ste 4, Indiana, Pennsylvania 15701-3571

Distribution

Quantity
22 bottles/90 count each
Distribution pattern
Recalled product was distributed to Florida.

Timeline

Recall initiated
2022-05-04
FDA classified
2022-05-20
Posted by FDA
2022-06-01
Terminated
2022-09-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0885-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.